IL6 and colorectal carcinoma: It can eventually increase the risk of CRC by increasing levels of vascular cell adhesion molecule-1, cytokines (interleukin-6 and tumor necrosis factor cytokine), and chemokines (high sensitivity C-reactive protein) and inducing the adhesion of T cells and monocytes [35–39].